Healthcare -
Biotechnology - NASDAQ - CH
$ 5.555
-0.626 %
$ 205 M
Market Cap
-2.68
P/E
MOLN - COST OF REVENUE
Cost of Revenue MOLN - Molecular Partners AG
47.8 M
LAST VALUE
-7.33%
2 YEAR CAGR
25.12%
5 YEAR CAGR
44.32%
10 YEAR CAGR